These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9334541)

  • 41. Neurogenetic determinism and the new euphenics. Child and adolescent psychiatrists use methylphenidate because it makes children better.
    Williams JH
    BMJ; 1999 May; 318(7196):1488-9. PubMed ID: 10419301
    [No Abstract]   [Full Text] [Related]  

  • 42. Explosive outbursts associated with methylphenidate.
    Adrian N
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
    [No Abstract]   [Full Text] [Related]  

  • 43. Medication for children with attention disorders.
    Kash IJ
    Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9164792
    [No Abstract]   [Full Text] [Related]  

  • 44. Methylphenidate and the cytochrome P450 system.
    Baird R
    Can J Psychiatry; 2003 Jul; 48(6):425-6; author reply 426. PubMed ID: 12894619
    [No Abstract]   [Full Text] [Related]  

  • 45. Novice drivers with attention-deficit hyperactivity disorder.
    Jerome L
    CMAJ; 2007 Jun; 176(12):1735. PubMed ID: 17548393
    [No Abstract]   [Full Text] [Related]  

  • 46. Methylphenidate: its pharmacology and uses.
    Challman TD; Lipsky JJ
    Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of long-term treatment with stimulant medication on growth?
    Poulton A
    J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):305. PubMed ID: 17314713
    [No Abstract]   [Full Text] [Related]  

  • 48. Methylphenidate-induced plasticity: what should we be looking for?
    Hyman SE
    Biol Psychiatry; 2003 Dec; 54(12):1310-1. PubMed ID: 14675793
    [No Abstract]   [Full Text] [Related]  

  • 49. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
    Swanson J; Baler RD; Volkow ND
    Neuropsychopharmacology; 2011 Jan; 36(1):207-26. PubMed ID: 20881946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to Dose Attention-Deficit/Hyperactivity Disorder Medications Without a Grain of Salt.
    Engelking D; Childress AC; McMahen R; Sikes CR
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):576-577. PubMed ID: 30085849
    [No Abstract]   [Full Text] [Related]  

  • 51. Methylphenidate: established and expanding roles in symptom management.
    Prommer E
    Am J Hosp Palliat Care; 2012 Sep; 29(6):483-90. PubMed ID: 22144657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive styles in hyperactive children and the effect of methylphenidate.
    Campbell SB; Douglas VI; Morgenstern G
    J Child Psychol Psychiatry; 1971 Jun; 12(1):55-67. PubMed ID: 23289169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Ritalin in preschoolers.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2000; 10(2):53-4. PubMed ID: 10933114
    [No Abstract]   [Full Text] [Related]  

  • 54. Case study: sexual hyperactivity treated with psychostimulants in familial male precocious puberty.
    Weissenberger AA; Leschek EW; Zametkin AJ
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):373-6. PubMed ID: 11288780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The possible effect of methylphenidate on kleptomania in a school-age girl with attention-deficit/hyperactivity disorder.
    Yılmaz S; Bilgiç A
    Eur Child Adolesc Psychiatry; 2014 May; 23(5):361-3. PubMed ID: 24122344
    [No Abstract]   [Full Text] [Related]  

  • 56. Attenuation of methylphenidate-induced tolerance on cognition by buspirone co-administration.
    Alam N; Najam R; Khan SS
    Pak J Pharm Sci; 2015 Sep; 28(5):1601-5. PubMed ID: 26408868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-hyperactivity medication: methylphenidate and amphetamine.
    Seeman P; Madras BK
    Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duloxetine Alleviates Stimulant Dysphoria, Helps With Enuresis, and Complements Cognitive Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder.
    Naguy A
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 28033457
    [No Abstract]   [Full Text] [Related]  

  • 59. Responders and nonresponders.
    Arnold LE
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1569-70. PubMed ID: 8973058
    [No Abstract]   [Full Text] [Related]  

  • 60. Attention deficit disorder: evaluation and treatment.
    Dulcan MK
    Pediatr Ann; 1985 May; 14(5):383-5, 388-90, 393-400. PubMed ID: 2860631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.